Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 36%
Sell 7%
Strong Sell 0%

Bulls say

Henry Schein is well-positioned in the healthcare industry, with a strong track record and competitive advantages. Its focus on value-added services, global distribution, and specialty products make it a key player in the market. With a solid financial position and promising growth opportunities, the company has the potential to continue delivering strong results and outperforming its competitors.

Bears say

Henry Schein is a company with potential for future growth, evident from its recent upgrade to a Buy rating. Its spin-off Envista also displays potential with strong earnings in the first quarter of 2026. However, HSIC faces competition in the dental market and relies on long-term contracts and third-party suppliers, which could be disrupted. Additionally, analysts have mixed recommendations for HSIC and the stability of the dental industry could impact HSIC's growth.

Henry Schein (HSIC) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 36% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Buy based on their latest research and market trends.

According to 14 analysts, Henry Schein (HSIC) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.